(Q54324687)

27 May 2018

title

Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature. (English)

1 reference

27 May 2018

Erratum: Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature

corrigendum / erratum

1 reference

DOI

10.1038/SJ.LEU.2405089

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/SJ.LEU.2405089

author

Rafael Fonseca

4

1 reference

27 May 2018

author name string

Chng WJ

1

1 reference

27 May 2018

Kuehl WM

2

1 reference

27 May 2018

Bergsagel PL

3

1 reference

27 May 2018

publication date

6 September 2007

1 reference

27 May 2018

published in

Leukemia

1 reference

27 May 2018

volume

22

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

459-461

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404934

exact match

0 references

cites work

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

The molecular classification of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404934

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2404934

1 reference

27 May 2018

PubMed ID

17805328

1 reference

27 May 2018